Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-10-04Clinical Trial Update: Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy [Phase 4]
Phase 4 trial comparing oral versus intravenous hydration to prevent contrast-induced nephropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN) [Phase 4]
Phase 4 trial evaluating fluid prophylaxis strategies to prevent Contrast Induced Nephropathy was withdrawn from the study status.
-
CLINICAL_TRIALS withdrawal · 2015-04-08Clinical Trial Update: Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography [NA]
A clinical trial investigating the renal protective effect of pentoxifylline in high-risk patients undergoing angiography has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2015-03-11Clinical Trial Update: Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage [Phase 2]
Phase 2 trial evaluating intravenous amino acid infusion to prevent contrast-induced nephropathy has been withdrawn.